Elacestrant Interactions
There are 227 drugs known to interact with elacestrant, along with 1 disease interaction, and1 alcohol/food interaction. Of the total drug interactions, 81 are major, 145 are moderate, and1 is minor.
- View elacestrant alcohol/food interactions (1)
- View elacestrant disease interactions (1)
Medications known to interact with elacestrant
Note: Showing generic names only.
A
- adagrasib
- afatinib
- aliskiren
- alpelisib
- alvimopan
- ambrisentan
- aminoglutethimide
- amobarbital
- amprenavir
- apalutamide
- apixaban
- apremilast
- aprepitant
- armodafinil
- artesunate
- atazanavir
- atorvastatin
B
- belinostat
- belzutifan
- berotralstat
- betrixaban
- bexarotene
- boceprevir
- bosentan
- bosutinib
- brentuximab
- brigatinib
- butabarbital
- butalbital
C
- cabazitaxel
- carbamazepine
- cenobamate
- ceritinib
- chloramphenicol
- ciprofloxacin
- cladribine
- clarithromycin
- clofazimine
- cobicistat
- cobimetinib
- colchicine
- conivaptan
- crizotinib
- cyclosporine
D
- dabigatran
- dabrafenib
- daclatasvir
- dactinomycin
- darolutamide
- darunavir
- deferasirox
- delafloxacin
- delavirdine
- dexamethasone
- digoxin
- diltiazem
- docetaxel
- doxorubicin
- doxorubicin liposomal
- dronedarone
- duvelisib
E
- edoxaban
- efavirenz
- elagolix
- eliglustat
- eltrombopag
- empagliflozin
- encorafenib
- enzalutamide
- erythromycin
- eslicarbazepine
- etoposide
- etravirine
- everolimus
F
- fedratinib
- felbamate
- fexinidazole
- fexofenadine
- fidaxomicin
- fluconazole
- fosamprenavir
- fosaprepitant
- fosphenytoin
G
H
I
- idarubicin
- idelalisib
- imatinib
- indacaterol
- indinavir
- irinotecan
- irinotecan liposomal
- isavuconazonium
- itraconazole
- ivermectin
- ivosidenib
- ixabepilone
K
L
- lapatinib
- larotrectinib
- lemborexant
- lenacapavir
- lenalidomide
- lesinurad
- letermovir
- levoketoconazole
- linagliptin
- lonafarnib
- lonapegsomatropin
- loperamide
- loratadine
- lorlatinib
- lurasidone
- lusutrombopag
M
- maraviroc
- mavorixafor
- mephobarbital
- methotrexate
- metreleptin
- mibefradil
- mifepristone
- mirabegron
- mitapivat
- mitomycin
- mitotane
- mitoxantrone
- modafinil
- morphine
N
- nafcillin
- naldemedine
- naloxegol
- nefazodone
- nelfinavir
- nevirapine
- nicardipine
- nilotinib
- nintedanib
- niraparib
O
P
- paclitaxel
- pazopanib
- pentobarbital
- pexidartinib
- phenobarbital
- phenylbutazone
- phenytoin
- pitolisant
- ponatinib
- posaconazole
- pralsetinib
- primidone
- prucalopride
Q
R
- ranolazine
- relugolix
- repotrectinib
- ribociclib
- rifabutin
- rifampin
- rifapentine
- rifaximin
- rimegepant
- riociguat
- ripretinib
- ritonavir
- rivaroxaban
- romidepsin
- rosuvastatin
- rucaparib
- rufinamide
S
- saquinavir
- saxagliptin
- secobarbital
- selexipag
- silodosin
- sirolimus
- sirolimus protein-bound
- sirolimus topical
- sitagliptin
- sofosbuvir
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sotorasib
- st. john's wort
- stiripentol
- sulfasalazine
- sulfinpyrazone
T
- tacrolimus
- talazoparib
- tazemetostat
- tecovirimat
- telaprevir
- telithromycin
- telotristat
- teniposide
- tenofovir alafenamide
- tenofovir disoproxil
- teriflunomide
- ticagrelor
- tipranavir
- tolvaptan
- topotecan
- tovorafenib
- trametinib
- troglitazone
- troleandomycin
- tucatinib
U
V
- vemurafenib
- venetoclax
- verapamil
- vibegron
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- voriconazole
- voxelotor
Z
Elacestrant alcohol/food interactions
There is 1 alcohol/food interaction with elacestrant.
Elacestrant disease interactions
There is 1 disease interaction with elacestrant which include:
More about elacestrant
- elacestrant consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: estrogen receptor antagonists
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.